Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination
Issue Cover
Current Issue
Volume 9,
Issue 2,
January 28 2025

Featured Content

A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT

Medicaid coverage continuity is associated with lymphoma stage among children and adolescents/young adults

Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network

Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response

Universal protection of allogeneic T-cell therapies from natural killer cells via CD300a agonism

EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals